Replies to post #69852 on MMRGlobal, Inc. (fka MMRF)

[big-yank]

100% of fast-food burger joints offer their customers a chance to purchase fries with their sandwich order.

I bet a lot more burger customers purchase a 50 cent order of fries than would ever consider buying a $99 box of crap from MMRF for some arcane PHR they can get for free from MSFT.

JMHO.

[Blue Sky Basin]

Excellent post and worth a look by everyone who posts on this board. Keep up the good work T$!

[EZ2]

The RHL Group

http://www.thalians.org/smokey.html

http://www.thalians.org/video.html

[EZ2]

Bob Lorsch and the boys are going to love this!!


U.S. top court overturns appeals court on fees in patent cases

REUTERS 2:16 PM ET 04/29/14
By Diane Bartz

WASHINGTON, April 29 (Reuters) - The U.S. Supreme Court threw out appeals court rulings in two patent cases on Tuesday, potentially making it easier for the winner of a patent lawsuit to have its legal fees paid by the losing party.

Patent experts said the cases would have a significant effect on the torrent of unwarranted patent litigation, some of it brought by companies derisively called "patent trolls."

In the first case, ICON Health & Fitness Inc sued a rival, Octane Fitness LLC, accusing Octane of infringing one of its patents on elliptical trainers. Octane won, and asked to be reimbursed for the $1.3 million it spent fighting the lawsuit. Both the U.S. district court and an appeals court that specializes in patents declined to award the fees.

The high court also threw out a ruling in a case regarding fee-shifting, where the loser pays in some instances. In that case, Allcare Health Management accused health insurer Highmark Inc of patent infringement but lost. The district court awarded Highmark attorney fees, but they were tossed out by the U.S. Court of Appeals for the Federal Circuit.

The Supreme Court sent both cases back to the lower court for reconsideration.

Justice Sonia Sotomayor, who wrote both opinions, said in the Octane case that the U.S. Court of Appeals for the Federal Circuit erred by being "too restrictive" in establishing standards for awarding attorney's fees.

"A district court may award fees in the rare case in which a party's unreasonable, though not independently sanctionable, conduct is so 'exceptional' as to justify an award," she wrote.

The high court also made it easier for companies to show that they should be reimbursed for legal fees by reducing the standard of proof from "clear and convincing evidence" to a "preponderance of the evidence."

Once a decision is made by a district court on awarding fees, the court's ruling in Highmark made it harder for an appeals court to overturn the award.

The Octane decision will give district court judges more leeway in awarding attorneys fees in cases that they think should not have been brought, said Jeanne Gills, a patent attorney with Foley & Lardner LLP. "I don't know that it's a game-changer but it's significant," she said.

Some companies, including big technology firms and retailers, complain about unwarranted lawsuits. Others, including some inventors, worry that their ability to fight infringement could be harmed if the rules are changed.

"It (the decisions) will make patent trolls think twice about bringing cases," said Stephen Holmes, a patent expert with Kaye Scholer LLP. "If they (patent holders) have a good case, and they litigate properly, they should still bring it."

The issue has been hotly lobbied in Washington. President Barack Obama has called on Congress to pass legislation aimed at reining in frivolous patent infringement lawsuits.

The U.S. House of Representatives voted on Dec. 5 to approve a bill that encourages judges hearing patent cases to award fees to the winner of an infringement lawsuit. The bill also requires companies filing such suits to detail which patent is infringed - something that does not now reliably happen.

Senator Patrick Leahy, chairman of the Judiciary Committee, has sponsored similar legislation which is scheduled to be considered on Thursday. (Reporting by Diane Bartz; editing by Susan Heavey, Phil Berlowitz and Tom Brown)

(c) Copyright Thomson Reuters 2014. Click For Restrictions - about.reuters.com/fulllegal.asp

[EZ2]

MMRGlobal Announces Significant Increases in Monthly Signups of Personal Health Record Accounts

MARKET WIRE 8:15 AM ET 05/12/14


LOS ANGELES, CA -- (Marketwired) -- 05/12/14 -- MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company") today announced that after the launch of the new home page for its patented MyMedicalRecords PHR in March, which can be seen at www.mymedicalrecords.com, signups for the Company's Personal Health Record accounts doubled in the first thirty days, with the trend continuing at a run rate of more than three hundred percent based on the first 10 days in May, without advertising. Given the early success, MMR will launch a new online media campaign starting this week based on keyword advertising, banners, affiliate programs and other forms of interactive online and smartphone advertising. The Company also announced that starting this summer, MMR will be running its new television commercial featuring Fran Drescher, TV's "The Nanny," in Associated Television International's programming (www.associatedtelevision.com), which is syndicated in more than 200 television markets, as part of a cause-related advertising campaign to sell Personal Health Records direct to consumers and benefit Cancer Schmancer. All of the Company's commercial advertising campaigns including the latest one featuring Ms. Drescher can be seen at www.mmrontv.com.

The Company also plans on announcing its first quarter 2014 results on May 15th in which revenue is projected to be the highest specifically coming from its core business of sales and licensing Personal Health Records products and services in the Company's history. MMR projects that trend will continue as it also launches a new national retail distribution program to more than 30 million consumers throughout the summer, starting this quarter.

MMRGlobal is a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions and MMRPro document management and imaging systems for healthcare professionals. The use of Personal Health Records is a key part of modernizing America's healthcare system and the government is spending hundreds of millions of dollars in education designed to empower patients to take greater control of their health, using tools such as a PHR.

About MMRGlobal
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. MMR's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, MMR acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of MMR's products and services at www.mmrtheater.com. Follow us at Facebook.com/MMRGlobal and Twitter.com/mmrglobal.

Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, including, without limitation, future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause MMR's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. The information discussed in this release is subject to various risks and uncertainties related to the MMR's business prospects, results of operations or financial condition; the risk our products and services are not adopted or viewed favorably by the healthcare community and consumer retail markets; unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both MMR's health IT and biotechnology intellectual property assets in the U.S. and internationally; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; marketing promotions and campaigns; product integration in physician practices and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; programs and initiatives; ability to establish and maintain strategic relationships; competitive product offerings and promotions; maintaining, developing and defending our intellectual property rights; marketing and exploitation of our patent portfolio; government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.'s public filings with the U.S. Securities and Exchange Commission. MMR is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

CONTACT:

Michael Selsman
Public Communications Co.
[e-mail]
[phone]